2010
DOI: 10.3390/molecules15128973
|View full text |Cite
|
Sign up to set email alerts
|

Preparation and Properties of New Co-Crystals of Ibandronate with Gluco- or Galactopyranoside Derivatives

Abstract: Mixtures of ibandronate monosodium salt with eleven gluco- and/or galacto-pyranoside derivatives as counterions were designed to prepare co-crystals with improved intestinal absorption. In general, gastrointestinal absorption of bisphosphonates after oral administration is approximately 1%. Co-crystals were generated by means of thermodynamically and/or kinetically controlled crystallization processes. Seventy-seven prepared samples were analyzed by means of FT-NIR, FT-Raman spectrometry and solid state NMR sp… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
13
0

Year Published

2012
2012
2024
2024

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 8 publications
(14 citation statements)
references
References 16 publications
1
13
0
Order By: Relevance
“…However, contrary to expectation, the evaluated co-crystals showed relatively low bioavailability [18]. Binding of a-and b-D-galactopyranosides with different hydrophobic aglycones to lactose permease of E. coli was compared [18]. The most potent new compound appeared to be m-nitrophenyl-a-D-galactopyranoside.…”
Section: Introductionmentioning
confidence: 95%
See 1 more Smart Citation
“…However, contrary to expectation, the evaluated co-crystals showed relatively low bioavailability [18]. Binding of a-and b-D-galactopyranosides with different hydrophobic aglycones to lactose permease of E. coli was compared [18]. The most potent new compound appeared to be m-nitrophenyl-a-D-galactopyranoside.…”
Section: Introductionmentioning
confidence: 95%
“…Only phenyl b-D-galactopyranoside yielded potential co-crystals with ibandronate probably due to cis-orientation of phenoxy moiety. However, contrary to expectation, the evaluated co-crystals showed relatively low bioavailability [18]. Binding of a-and b-D-galactopyranosides with different hydrophobic aglycones to lactose permease of E. coli was compared [18].…”
Section: Introductionmentioning
confidence: 98%
“…6, structure IV) or risedronate (see Fig. 6, structure V) with a number of carbohydrates as co-crystal formers (Jampílek et al, 2009;Haroková, 2010;Havelková, 2010;Hrušková, 2010;Jampílek et al, 2010;Kos et al, 2011;Ťažká 2011;Havelková, 2012;Oktábec, 2012). The present study deals with the design and an effort to prepare co-crystals/new entities, generally new solid phases, of the above discussed bisphosphonates III-V.…”
Section: Carbohydrates and Their Derivatives As Crystallization Modifmentioning
confidence: 99%
“…All generated solid compounds were subsequently screened by means of FT-NIR and FT-Raman spectroscopy. If a sample differing from the starting materials was found, it was additionally characterized by the below mentioned methods (Jampílek et al, 2009;Haroková, 2010;Havelková, 2010;Hrušková, 2010;Jampílek et al, 2010;Kos et al, 2011;Ťažká 2011;Havelková, 2012;Oktábec, 2012). Figure 11.…”
Section: Generation Of Samplesmentioning
confidence: 99%
See 1 more Smart Citation